Health/Disease Strategy

Humana Targets Social Determinants of Health, Improves Outcomes in 2 Cities

April 16, 2018

How Humana is successfully improving care for members in two cities.

How to Treat Substance Abuse with a Model of Ongoing Care

April 13, 2018

Here's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.

Burnout Hits Oncologists Hard, but Healthcare Systems Can Help

April 10, 2018

Healthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.

How RA, Cancer, Hep C Drug Costs Will Change Over Next Five Years

April 06, 2018

Experts weigh in on the spending outlook for these high-cost conditions.

Gene Therapy Advances: What Health Execs Should Know

April 05, 2018

Gene therapy is leaving its mark, while payers contemplate payment models, value, and efficacy issues.

Economic Stress Has Negative Impact on Patients’ Health

March 30, 2018

A UCLA study shows that the Great Recession intensified patients’ cardiovascular risk factors.

Readmission Cost Savings are a Reality with Enhanced Patient Engagement

March 18, 2018

Reduce readmissions by focusing on better engagement with patients and improving coordination from inpatient to outpatient settings.

Opinion: Telepsychiatry needed to bridge gap for rural VA patients

March 16, 2018

Unfortunately, the issue for many vets who experience trauma is that the mental health services they need are too far away from home. Here’s one solution.

Seven diseases benefiting from genetic tests

March 01, 2018

Genetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.

What Roche’s Purchase of Flatiron Health Means for Health Execs

February 28, 2018

Switzerland-based pharma company Roche’s $1.9 billion purchase of tech company Flatiron Health signifies Big Pharma’s need for data.